Nganou-Makamdop, K., Billingsley, J. M., Yaffe, Z., O’Connor, G., Tharp, G. K., Ransier, A., . . . Douek, D. C. (2018). Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication. PLoS pathogens, 14(8), e1007246. https://doi.org/10.1371/journal.ppat.1007246
Citace podle Chicago (17th ed.)Nganou-Makamdop, Krystelle, et al. "Type I IFN Signaling Blockade by a PASylated Antagonist During Chronic SIV Infection Suppresses Specific Inflammatory Pathways but Does Not Alter T Cell Activation or Virus Replication." PLoS Pathogens 14, no. 8 (2018): e1007246. https://doi.org/10.1371/journal.ppat.1007246.
Citace podle MLA (9th ed.)Nganou-Makamdop, Krystelle, et al. "Type I IFN Signaling Blockade by a PASylated Antagonist During Chronic SIV Infection Suppresses Specific Inflammatory Pathways but Does Not Alter T Cell Activation or Virus Replication." PLoS Pathogens, vol. 14, no. 8, 2018, p. e1007246, https://doi.org/10.1371/journal.ppat.1007246.